Cyclosporine A loaded self-nanoemulsifying drug delivery system (SNEDDS): implication of a functional excipient based co-encapsulation strategy on oral bioavailability and nephrotoxicity
- 20 May 2015
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 5 (61) , 49633-49642
Abstract
The present work focusses on the formulation development and evaluation of a functional excipient (surfactant stabilizer), a vitamin E TPGS loaded self-nanoemulsifying drug delivery system (SNEDDS), for improving the deliverability and safety profile of cyclosporine A (CyA). The saturation solubility of individual bioactive compounds were evaluated in a series of oils and surfactants. In addition, a ternary phase diagram-based exhaustive optimization was performed to identify the nanoemulsification region that yields the desired quality of attributes and maximum loading capacity of CyA and vitamin E TPGS. The optimized formulation exhibited excellent stability in simulated gastrointestinal fluids. In vitro drug release studies revealed significantly higher rapid release of CyA from CyA-TPGS SNEDDS as compared to that of the clinically available counterpart Bioral® or in-house CyA-SNEDDS. In vivo pharmacokinetics further demonstrated a 4.48-fold increase in oral bioavailability in the case of the developed formulation as compared to Bioral®. CyA induced reactive oxygen species (ROS) generation in HEK cell lines was significantly diminished in the case of CyA-TPGS SNEDDS in contrast to that of CyA SNEDDS, Bioral® and the CyA + vitamin E TPGS physical mixture. The results were further corroborated by in vivo nephrotoxicity studies wherein the levels of biochemical markers of nephrotoxicity, blood urea nitrogen and serum creatinine levels were comparable to that of a negative control in the case of the developed formulation in contrast to that of Bioral®. In a /nutshell, the employed strategy of functional excipient loaded SNEDDS poses a viable strategy for developing value-added nanoformulations of CyA.Keywords
This publication has 28 references indexed in Scilit:
- Co-encapsulation of Tamoxifen and Quercetin in Polymeric Nanoparticles: Implications on Oral Bioavailability, Antitumor Efficacy, and Drug-Induced ToxicityMolecular Pharmaceutics, 2013
- Effect of co-administration of CoQ10-loaded nanoparticles on the efficacy and cardiotoxicity of doxorubicin-loaded nanoparticlesRSC Advances, 2013
- Gelatin Coated Hybrid Lipid Nanoparticles for Oral Delivery of Amphotericin BMolecular Pharmaceutics, 2012
- Nanoparticles made of multi-block copolymer of lactic acid and ethylene glycol containing periodic side-chain carboxyl groups for oral delivery of cyclosporine AJournal of The Royal Society Interface, 2010
- PLGA nanoparticles for oral delivery of cyclosporine: Nephrotoxicity and pharmacokinetic studies in comparison to Sandimmune Neoral®Journal of Controlled Release, 2007
- Design and evaluation of self-nanoemulsifying drug delivery systems (SNEDDS) for cefpodoxime proxetil☆International Journal of Pharmaceutics, 2007
- Oral bioavailability of cyclosporine: Solid lipid nanoparticles (SLN®) versus drug nanocrystalsInternational Journal of Pharmaceutics, 2006
- α‐Tocopherol and α‐Lipoic Acid Enhance the Erythrocyte Antioxidant Defence in Cyclosporine A‐Treated RatsBasic & Clinical Pharmacology & Toxicology, 2006
- Depressed renal and vascular nitric oxide synthase expression in cyclosporine-induced hypertensionKidney International, 1998
- Cyclosporine A in the Treatment of Psoriasis: A Clinical and Mechanistic PerspectiveJournal of Investigative Dermatology, 1990